Figure 1From: Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trialStudy design of the SCLEROCYST trial. AS, aspiration and sclerotherapy; INJ, injection of pasireotide or placebo; Q, assessment of GIS-, PLD- and SF-36 questionnaires; US, ultrasonography.Back to article page